Sn Holdings, LLC

Reporting payments is a legal requirement; large totals often reflect large product portfolios.

$1.3Mgeneral payments (2019-2025)
$0.00research payments (2019-2025)
244clinicians paid

General and research payments are shown separately, never blended. Research payments are often institution-directed and tied to clinical trials.

General payments by year

2021 $137K
2022 $490K
2023 $522K
2024 $105K

General payments only, as reported to CMS. Research payments are totaled above and not included in these bars.

Specialties it works with most

Urology $1.1M
Rheumatology $166K
Gastroenterology (Internal Medicine) $350

Clinicians with the largest reported totals

Often long-running consulting, speaking, or advisory relationships, which companies must report by law. A large total is not evidence of anything improper.

ClinicianLocationSpecialtyGeneral payments (2019-2025)
Neal Shore Myrtle Beach, SC Urology $442,496.27
Max Hamburger Melville, NY Rheumatology $166,383.38
Gautam Jayram Nashville, TN Urology $157,653.52
Bryan Mehlhaff Springfield, OR Urology $62,814.78
Michael Fabrizio Virginia Beach, VA Urology $52,641.18
Vahan Kassabian Roswell, GA Urology $42,530.09
David Morris Hendersonville, TN Urology $39,353.30
Daniel Saltzstein San Antonio, TX Urology $39,023.23
Richard Harris Melrose Park, IL Urology $37,326.43
Benjamin Lowentritt Baltimore, MD Urology $31,859.00

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.